Skip to main content

Day: May 28, 2020

Neurodegenerative Diseases Drugs Market to Exhibit 7.2% CAGR till 2026; Rising Geriatric Population to Aid Growth: Fortune Business Insights™

Pune, May 28, 2020 (GLOBE NEWSWIRE) — The global neurodegenerative diseases drugs market is likely to gain traction from the rising incidence of neurodegenerative diseases worldwide. Such diseases pose a greater burden on the physical and mental health of the populaces, as well as on the healthcare cost. This information is given by Fortune Business Insights™ in a published report, titled, “Neurodegenerative Diseases Drugs Market Size, Share and Industry Analysis By Drug Class (Immunomodulator, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Others), By Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer’s Disease, Spinal Muscular Atrophy (SMA), Others), By Route of Administration (Oral, Injection, Transdermal, Others), By End User and Regional Forecast 2019-2026.” The report further states that...

Continue reading

Apple Rush Clarifies Relationship with Hard Rush™ as It Approaches Launch

TITUSVILLE, Fla., May 28, 2020 (GLOBE NEWSWIRE) — The Apple Rush Company, Inc. (US OTC PINK: APRU), clarifies for its shareholders that it jointly owns the trademark for the Hard Rush™ brand, a newly developed seltzer juice and alcohol beverage.The company has joint ownership of the trademark rights with Hard Rush, Inc., developer of the product and which is a private company headed by Robert Corr, former President of Apple Rush. APRU, LLC is a subsidiary of the Apple Rush Co. Inc., and is the public entity traded as APRU. In the event of a future sale of the trademark the benefit will be equal to both parties.  Moreover, Apple Rush’s Pomegranate juice will be a prime ingredient in the formula of Hard Rush™, which is expected to be its best selling flavor.  “Many mutual opportunities and benefits will ensue, accordingly,” said APRU...

Continue reading

Financière de L’Odet : Assemblées Générales du 28 Mai 2020

FINANCIÈRE DE L’ODETCommuniqué de presse – le 28 mai 2020ASSEMBLÉES GÉNÉRALES DU 28 MAI 2020TOUTES LES RÉSOLUTIONS ONT ÉTÉ ADOPTÉES À PLUS DE 98 %Les Assemblées générales ordinaire et extraordinaire de Financière de l’Odet SE se sont tenues le 28 mai 2020 à huis clos, sous la présidence de Vincent Bolloré.91,9 % du capital ont voté à l’assemblée. L’ensemble des résolutions présentées au cours des Assemblées ont été adoptées entre 98,04 % et 99,99 %.L’Assemblée générale ordinaire a notamment approuvé le renouvellement des mandats d’administrateur de Marie Bolloré et d’Olivier Roussel, et a ratifié les cooptations de Mesdames Ingrid Brochard, Janine Goalabré, Lynda Hadjadj, Valérie Hortefeux et de Monsieur Gilles Alix,.Enfin, la distribution du dividende de 1€, égal à celui de l’année précédente sera versé le 8 juin prochain.AttachmentCommuniqué...

Continue reading

Progress MOVEit 2020 Improves Secure File Transfer for Remote Workforces and Provides Native Support for Hybrid Cloud Architectures

New release introduces free enhanced mobile app and eases scaling and integrationBEDFORD, Mass., May 28, 2020 (GLOBE NEWSWIRE) — Progress (NASDAQ: PRGS), the leading provider of application development and digital experience technologies, today announced the release of Progress® MOVEit® 2020, the secure, automated Managed File Transfer (MFT) solution that can be deployed on-premises and in the cloud. The new release comes equipped with MOVEit Mobile 2.0, as well as enhanced cloud, integration and performance capabilities.“Demand for secure file transfer in hybrid environments has increased over the past few months as large files are being exchanged with remote team members and partners in virtual work environments,” said Stewart Bond, research director, Data Integration and Intelligence software research at IDC. “MOVEit 2020 is...

Continue reading

Mortgage Rates Hit Another All-Time Low

MCLEAN, Va., May 28, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing that the 30-year fixed-rate mortgage (FRM) averaged 3.15 percent.“The 30-year fixed-rate mortgage has again hit the lowest level in our survey’s nearly 50-year history, breaking the record for the third time in just the last few months,” said Sam Khater, Freddie Mac’s Chief Economist. “These unprecedented rates have certainly made an impact as purchase demand rebounded from a 35 percent year-over-year decline in mid-April to an 8 percent increase as of last week—a remarkable turnaround given the sharp contraction in economic activity. Additionally, refinance activity remains elevated and low mortgage rates have been accompanied by a $70,000 decline in the average loan size of refinance...

Continue reading

Hemostats Market Anticipated to Reach USD 5.44 Billion by 2027; Rising Number of Chronic Ailments to Add Impetus to Market, says Fortune Business Insights™

Pune, May 28, 2020 (GLOBE NEWSWIRE) — The global hemostats market size is anticipated to USD 5.44 billion by the end of 2025. The growth of this region is accountable for the increasing incidences of sports-related injuries worldwide. A hemostat is a surgical tool used for controlling the flow of blood at the time of performing operations. According to a recent report by Fortune Business Insights titled, “Hemostats Market Size, Share & Industry Analysis, By Product Type (Active Hemostats, Passive Hemostats, Combination Hemostats, Others), By Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Others), By End, User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers, Others) and Regional Forecast, 2018-2025,” the value of this market was...

Continue reading

Atossa Therapeutics Announces Second COVID-19 Therapeutic Development Program, AT-301 Nasal Spray: Summit Biosciences Retained to Develop and Supply AT-301 Nasal Spray for Clinical Study

SEATTLE, May 28, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced that it has begun the development of a second COVID-19 program using its proprietary drug candidate AT-301, to be administered by nasal spray.AT-301 is Atossa’s proprietary formula intended for nasal administration in patients immediately following diagnosis of COVID-19 but who have not yet exhibited symptoms severe enough to require hospitalization. It is intended for at-home use to proactively reduce symptoms of COVID-19 and to slow the infection rate so that a person’s immune system can more effectively fight SARS-CoV-2 (coronavirus). Atossa also...

Continue reading

Immunology Market to Exhibit a CAGR of 8.1% by 2026; Growing R&D Investment by Major Players to Aid Development, states Fortune Business Insights™

Pune, May 28, 2020 (GLOBE NEWSWIRE) — The global immunology market size is predicted to reach USD 143,833.2 million by 2026, exhibiting a CAGR of 8.1% during the forecast period. The growing cases of immunological and autoimmune diseases will aid the growth of the market during the forecast period, states Fortune Business Insights in a report, titled “Immunology Market Size, Share and Industry Analysis By Drug Class (Monoclonal antibody (mAb), Fusion Proteins, Immunosuppressant, Polyclonal antibody (pAb), Others), By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, Others), By Distribution Channel, and Regional Forecast 2019-2026” the market size stood at USD 77,365.4 million in 2018. The growing R&D investment...

Continue reading

Glen Eagle Has Restarted its Operations in Honduras

MONTREAL, May 28, 2020 (GLOBE NEWSWIRE) — Glen Eagle Resources Inc. (TSX VENTURE: GER) (“Glen Eagle” or the “Company”) is pleased to announce that Cobra Oro gold processing plant has restarted its operations on May 15, 2020 with the current production to be exported in early June. The early restart was made possible by obtaining a special working permit as the country is still under an extended lockdown due to the pandemic.Cobra Oro has added a third production shift on May 25th and its operations are now running 24 hours a day, 5 days a week. Weekends are still under total lockdown across the country.Jean Labrecque, PresidentGlen Eagle Resources IncComplexe du Canal Lachine, Suite 3084710 St-Antoine StreetMontreal (Quebec)CanadaTel : 514-808-9807“Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.